drugset
Drugs / 15-Valent Pneumococcal Conjugate Vaccine
last change Mar 2026 re-read 9 days ago

15-Valent Pneumococcal Conjugate Vaccine

Vaccine

Developed for
streptococcal pneumonia · pneumococcal infection
Investigated by
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Hebei Provincial Center for Diseases Control and Prevention · Laishui Center for Disease Control and Prevention · National Institutes for Food and Drug Control, China · Simoon Record Pharma Information Consulting Co., Ltd.

Trials 4

today NCT05939219 · not/applicable NCT06817187 · Ph 3 NCT04357522 · Ph 3 NCT04108845 · Ph 1
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT04108845 Jun 2019 → Aug 2020 streptococcal pneumonia Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Unknown No outcome recorded
Phase 32 trials
Phase 3 NCT06817187 Sep 2021 → Mar 2024 pneumococcal infection Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Completed No outcome recorded
Phase 3 NCT04357522 Jul 2020 → Mar 2026 streptococcal pneumonia Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Unknown No outcome recorded
Phase not applicable1 trial
— NCT05939219 Jul 2023 → Jan 2025 — Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Unknown No outcome recorded
Comparator or background therapy1 trial
Phase 2 NCT06524414 Comparator Jul 2024 → May 2027 expected pneumococcal infection Pfizer Active not recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as 15-valent pneumococcal conjugate vaccine “15-valent pneumococcal conjugate vaccine” NCT06817187 ↗
5

NCT06524414 ↗

NCT04108845 ↗

NCT05939219 ↗

NCT06817187 ↗

NCT04357522 ↗
Modality Vaccine “15-Valent Pneumococcal Conjugate Vaccine” NCT04108845 ↗
Route Intramuscular “Single intramuscular dose” NCT04108845 ↗